Inventor · disambiguated record
Peter Bowers
Also filed as: BOWERS PETER · BOWERS PETER M · BOWERS PETER MICHAEL
16 granted patents·13 pending applications·90 citations·filing 1995–2024
92Inventor score
Top patents by PatentIndex Score
29 records- 0193US10526410B2Antibodies directed against interleukin 36 receptor (IL-36R)ANAPTYSBIO INC·Filed 2016·Granted Jan 7, 2020·7 cites·28 claims
- 0293US8603950B2Methods of generating libraries and uses thereofBOWERS PETER M·Filed 2008·Granted Dec 10, 2013·18 cites·7 claims
- 0392US8685897B2Methods of generating libraries and uses thereofBOWERS PETER M·Filed 2011·Granted Apr 1, 2014·13 cites·10 claims
- 0491US12065489B2Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2022·Granted Aug 20, 2024·2 cites·59 claims
- 0590US9133269B2Humanized antibodies directed against complement protein C5ANAPTYSBIO INC·Filed 2013·Granted Sep 15, 2015·20 cites·34 claims
- 0688US11130814B2Method of treating pustular psoriasis with antibodies directed against interleukin 36 receptor (IL-36R)ANAPTYSBIO INC·Filed 2019·Granted Sep 28, 2021·2 cites·27 claims
- 0788US10658995B1Calibration of bone conduction transducer assemblyFACEBOOK TECH LLC·Filed 2019·Granted May 19, 2020·8 cites·18 claims
- 0880US2025066469A1Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0973US10836824B2Antibodies directed against lymphocyte activation gene 3 (LAG-3)ANAPTYSBIO INC·Filed 2016·Granted Nov 17, 2020·1 cites·10 claims
- 1072US12391761B2Antibodies directed against interleukin 36 receptor (IL-36R)ANAPTYSBIO INC·Filed 2021·Granted Aug 19, 2025·0 cites·18 claims
- 1169US12410223B2TNF-alpha variant fusion moleculesTREX BIO INC·Filed 2024·Granted Sep 9, 2025·0 cites·23 claims
- 1268US9260533B2Methods of generating libraries and uses thereofANAPTYSBIO INC·Filed 2014·Granted Feb 16, 2016·0 cites·34 claims
- 1367US9637556B2Methods of generating libraries and uses thereofANAPTYSBIO INC·Filed 2013·Granted May 2, 2017·0 cites·7 claims
- 1465US9951126B2Antibodies directed against nerve growth factor (NGF)ANAPTYSBIO INC·Filed 2014·Granted Apr 24, 2018·0 cites·2 claims
- 1565US2024158495A1Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses ThereofTESARO INC·Filed 2023·Application pending·0 cites
- 1664US2021095026A1Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)ANAPTYSBIO INC·Filed 2020·Application pending·0 cites
- 1763US2022162299A1Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1862US2019256596A1Antibodies directed against lymphocyte activation gene 3 (lag-3)ANAPTYSBIO INC·Filed 2019·Application pending·0 cites
- 1960US2012028301A1Somatic hypermutation systemsHORLICK ROBERT A·Filed 2011·Application pending·0 cites
- 2059US2011183855A1Somatic hypermutation systemsANAPTYSBIO INC·Filed 2010·Application pending·0 cites
- 2158US5609378AAutomatic crane hook safety latchLATCHIT ENTERPRISES INC·Filed 1995·Granted Mar 11, 1997·19 cites·12 claims
- 2257US8926978B2Antibodies directed against nerve growth factor (NGF)ANAPTYSBIO INC·Filed 2012·Granted Jan 6, 2015·0 cites·2 claims
- 2357US2025131415A1Blockchain-Authenticated Communication Subscription SystemBOWERS PETER·Filed 2024·Application pending·0 cites
- 2453US2022135670A1Antibody agents directed against lymphocyte activation gene-3 (lag-3) and uses thereofTESARO INC·Filed 2018·Application pending·0 cites
- 2547US2022177583A1Claudin-6 bispecific antibodiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2645US2013102031A1Use of somatic hypermutation to create insertion and deletion mutations in vitroANAPTYSBIO INC·Filed 2012·Application pending·0 cites
- 2742US2014079691A1Thermostable antibody framework regionsANAPTYSBIO INC·Filed 2013·Application pending·0 cites
- 2833US9328166B2Antibodies directed against IL-17HORLICK ROBERT·Filed 2011·Granted May 3, 2016·0 cites·23 claims
- 2927US2002052317A1Anti-viral and anti-tumor chemotherapy by administration of erythropoeitinFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Bowers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →